0001874823-23-000002.txt : 20231206 0001874823-23-000002.hdr.sgml : 20231206 20231206134105 ACCESSION NUMBER: 0001874823-23-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 EFFECTIVENESS DATE: 20231206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sensorium Therapeutics, Inc. CENTRAL INDEX KEY: 0001874823 IRS NUMBER: 863181021 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-460645 FILM NUMBER: 231469068 BUSINESS ADDRESS: STREET 1: 25 CRESCENT STREET STREET 2: UNIT 135 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 5626885433 MAIL ADDRESS: STREET 1: 25 CRESCENT STREET STREET 2: UNIT 135 CITY: WALTHAM STATE: MA ZIP: 02453 D/A 1 primary_doc.xml X0708 D/A LIVE 0001874823 Sensorium Therapeutics, Inc. 40 GUEST STREET BOSTON MA MASSACHUSETTS 02134 617-744-2220 #800 DELAWARE None None Corporation true 2021 Richard Simon c/o Sensorium Therapeutics, Inc. 40 Guest Street Boston MA MASSACHUSETTS 02134 Executive Officer Director Jerrold Rosenbaum c/o Sensorium Therapeutics, Inc. 40 Guest Street Boston MA MASSACHUSETTS 02134 Director Pranav Tadi c/o Sensorium Therapeutics, Inc. 40 Guest Street Boston MA MASSACHUSETTS 02134 Executive Officer Kevin Lalande c/o Sensorium Therapeutics, Inc. 40 Guest Street Boston MA MASSACHUSETTS 02134 Director Ryan Katz c/o Sensorium Therapeutics, Inc. 40 Guest Street Boston MA MASSACHUSETTS 02134 Director Pharmaceuticals Decline to Disclose 06b true 0001874823-22-000002 2022-09-19 true true false 0 24789809 24689802 100007 false 64 0 true 0 true The Company engaged Umergence LLC (CRD# 284368) to introduce investors to the Company in connection with the financing. 750000 true false Sensorium Therapeutics, Inc. /s/ Pranav Tadi Pranav Tadi VP, Head of Finance 2023-12-05